Section on Nephrology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina 27157-1053, USA.
J Clin Endocrinol Metab. 2010 Mar;95(3):1076-83. doi: 10.1210/jc.2009-1797. Epub 2010 Jan 8.
Inverse associations are reported between circulating 25-hydroxyvitamin D and visceral adiposity. The effects of vitamin D levels on atherosclerosis are unknown.
The objective of this study was to test for relationships between vitamin D, adiposity, bone density, and atherosclerosis in African-Americans.
Circulating 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, intact PTH, C-reactive protein and computed tomography-derived calcified atherosclerotic plaque (CP), bone density, and fat volumes were measured.
Examinations were performed at a single outpatient general clinical research center visit.
Three hundred forty African-Americans with type 2 diabetes were evaluated. Mean +/- SD age was 55.6 +/- 9.6 yr, diabetes duration 10.6 +/- 8.3 yr, glomerular filtration rate 1.6 +/- 0.5 ml/sec, body mass index 35.6 +/- 8.7 kg/m(2), and 25-hydroxyvitamin D concentration 50.4 +/- 30.5 nmol/liter.
Biomarkers were tested for association with pericardial, visceral, im, and sc adipose tissues; thoracic and lumbar vertebral bone density; and aorta, coronary, and carotid artery CP.
Adjusting for age, gender, body mass index, glycosylated hemoglobin, and glomerular filtration rate, 25-hydroxyvitamin D was negatively associated with visceral adiposity (P = 0.009) and positively associated with carotid artery CP and aorta CP (P = 0.013 and 0.014, respectively) but not with coronary artery CP or bone density.
We confirmed an inverse association between vitamin D and visceral adiposity in African-Americans with diabetes. In addition, positive associations exist between 25-hydroxyvitamin D and aorta and carotid artery CP in African-Americans. The effects of supplementing vitamin D to raise the serum 25-hydroxyvitamin D level on atherosclerosis in African-Americans are unknown. Prospective trials are needed to determine the cardiovascular effects of supplemental vitamin D in this ethnic group.
循环 25-羟维生素 D 与内脏肥胖呈负相关。维生素 D 水平对动脉粥样硬化的影响尚不清楚。
本研究旨在检测非裔美国人的维生素 D、肥胖、骨密度和动脉粥样硬化之间的关系。
测量循环 25-羟维生素 D、1,25 二羟维生素 D、完整甲状旁腺激素、C 反应蛋白和计算机断层扫描(CT)衍生的钙化动脉粥样硬化斑块(CP)、骨密度和脂肪量。
在单个门诊普通临床研究中心进行检查。
评估了 340 名患有 2 型糖尿病的非裔美国人。平均年龄为 55.6±9.6 岁,糖尿病病程为 10.6±8.3 年,肾小球滤过率为 1.6±0.5ml/sec,体重指数为 35.6±8.7kg/m²,25-羟维生素 D 浓度为 50.4±30.5nmol/L。
检测生物标志物与心包、内脏、肌内和皮下脂肪组织、胸腰椎骨密度以及主动脉、冠状动脉和颈动脉 CP 的相关性。
在调整年龄、性别、体重指数、糖化血红蛋白和肾小球滤过率后,25-羟维生素 D 与内脏肥胖呈负相关(P=0.009),与颈动脉 CP 和主动脉 CP 呈正相关(P=0.013 和 0.014),但与冠状动脉 CP 或骨密度无关。
我们证实了维生素 D 与非裔美国人糖尿病患者内脏肥胖之间的负相关。此外,25-羟维生素 D 与非裔美国人的主动脉和颈动脉 CP 呈正相关。补充维生素 D 以提高血清 25-羟维生素 D 水平对非裔美国人动脉粥样硬化的影响尚不清楚。需要前瞻性试验来确定该族裔人群补充维生素 D 的心血管影响。